J&J announces study evidence backing booster shot
FILE – In this April 8, 2021 file photo, the Johnson & Johnson COVID-19 vaccine is seen at a pop up vaccination site in the Staten Island borough of New York. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine bulk substance to resume, the company said Thursday, July 29. The Baltimore factory was shut down by the FDA in mid-April due to contamination problems that forced the company to trash the equivalent of tens of millions of doses of vaccine it was making under contract for Johnson & Johnson. (AP Photo/Mary Altaffer, File)
ovp test
Male shot by female at Shreveport apartment
Class to create biodiverse backyard
Rules for outbursts at Caddo School Board Meeting
NEW BRUNSWICK, N.J. (NewsNation Now) Johnson & Johnson Wednesday announced that its current single-dose vaccine shot can work well as a booster shot, according to a press release.
Interim data from two studies conducted by the company indicated a “rapid and robust” immune system response to the booster when given 8 months after the initial dose.
It’s important to note that this is not the Food and Drug Administration’s approval of the J&J booster dose. While companies submit findings from studies to the agency routinely, they do not guarantee approval.
“We have established that a single shot of our COVID-19 vaccine generates strong and robust immune responses that are durable and persistent through eight months. With these new data, we also see that a booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, Johnson & Johnson. “We look forward to discussing with public health officials a potential strategy for our Johnson & Johnson COVID-19 vaccine, boosting eight months or longer after the primary single-dose vaccination.”
There had been widespread speculation over how the booster shot system would work with the single-dose vaccine. The Centers for Disease Control and Prevention has already rolled out plans for boosters for the Pfizer and Moderna two-shot vaccines.
The booster plan calls for an extra dose eight months after people get their second shot of the Pfizer or Moderna vaccine. The doses could begin the week of Sept. 20.
National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci said Monday that the latest immunological data shows that a booster shot increases protection against COVID-19 ten-fold which is among the reasons health officials gave the recommendation.
Earlier this week, the FDA gave full approval to Pfizer’s COVID-19 vaccine, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutation yet.
